Clinical data from infants enrolled in the Interfant treatment protocol revealed that NG2high iMLLr-B-ALL patients presented threefold higher number of circulating blasts, suggesting that NG2 is upregulated in response to systemic infiltration/migration, suggestive of a homeostatic adaptation of leukemic cells. The gene discussed is CSPG4; the disease is acute lymphoblastic leukemia.